Home/Filings/4/0001562180-19-004670
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-19-004670

CIK 0001597553other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:33 PM ET

Size

9.0 KB

Accession

0001562180-19-004670

Insider Transaction Report

Form 4
Period: 2019-09-04
Kanes Stephen
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-09-04$0.45/sh+6,000$2,7008,292 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-09-046,00086,100 total
    Exercise: $0.45Exp: 2023-07-23Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 18, 2017.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:33 PM ET
Size
9.0 KB